Osprey Pharmaceuticals Receives $3,800,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=872d4a3a-cdaf-4d34-a6f3-68f6838a2170&Preview=1 -
Date
5/27/2009 -
Company Name
Osprey Pharmaceuticals -
Mailing Address
425 California Street San Francisco, CA 94104 -
Company Description
Osprey Pharmaceuticals USA, together with its Montreal, Canada partner, Osprey Pharmaceuticals, Ltd., is developing a series of novel fusion protein therapeutics which selectively target and neutralize activated leukocytes that are implicated in a variety of inflammatory and immune disorders. -
Website
http://www.ospreypharma.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$3,800,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Burrill & Company -
Venture Investor
BDC Venture Capital -
Venture Investor
GeneChem -
Venture Investor
Western Technology Investment -
Venture Investor
Novo Nordisk Biotech Fund -
Venture Investor
Yasuda Enterprise Development
